Progression and Tumor Heterogeneity Analysis in Early Rectal Cancer

Purpose: Adequate preoperative staging of large sessile rectal tumors requires identifying adenomas that already contain an invasive focus, specifically those that are growing in or beyond the submucosa. We systematically compared chromosomal instability patterns in adenoma and carcinoma fractions of the same lesion to assess specific steps in rectal tumor progression. Experimental Design: We analyzed 36 formalin-fixed, paraffin-embedded tumors. Both the adenoma and carcinoma fractions were typed with single nucleotide polymorphism arrays and compared with 21 previously described pure adenomas. Eighteen cases were included in an intratumor heterogeneity analysis. Results: Five specific “malignant” events (gain of 8q, 13q, and 20q and loss of 17p and 18q) and aberrant staining for p53 and SMAD4 were all increased in the adenoma fractions of carcinoma cases compared with pure adenomas. Paired analysis revealed that 31% of the samples had an equal amount of malignant aberrations in their adenoma and carcinoma fractions, whereas 25% had one and 33% had two or more extra malignant events in the carcinoma fraction. Analysis of three core biopsies per patient showed a large degree of intratumor heterogeneity. However, the number of malignant aberrations in the biopsy with the most aberrations per tumor correlated with the corresponding adenoma or carcinoma fraction (r = 0.807; P < 0.001). Conclusion: Five specific chromosomal aberrations, combined with immunohistochemistry for p53 and SMAD4, can predict possible progression of sessile rectal adenomas to early rectal cancer and can, after validation studies, be added to preoperative staging. Preferably, three biopsies should be taken from each tumor to address intratumor heterogeneity.

[1]  W. Hop,et al.  The Role of Endorectal Ultrasound in Therapeutic Decision-Making for Local vs. Transabdominal Resection of Rectal Tumors , 2008, Diseases of the colon and rectum.

[2]  H. Morreau,et al.  Single nucleotide polymorphism array analysis of chromosomal instability patterns discriminates rectal adenomas from carcinomas , 2007, The Journal of pathology.

[3]  Carissa A. Sanchez,et al.  Increasing genomic instability during premalignant neoplastic progression revealed through high resolution array‐CGH , 2007, Genes, chromosomes & cancer.

[4]  Cisca Wijmenga,et al.  High-resolution copy number analysis of paraffin-embedded archival tissue using SNP BeadArrays. , 2007, Genome research.

[5]  A. Heintz,et al.  The Influence of Histopathologic Criteria on the Long-Term Prognosis of Locally Excised pT1 Rectal Carcinomas: Results of Local Excision (Transanal Endoscopic Microsurgery) and Immediate Reoperation , 2006, Diseases of the colon and rectum.

[6]  D. Kerr,et al.  Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  Carissa A. Sanchez,et al.  Genetic clonal diversity predicts progression to esophageal adenocarcinoma , 2006, Nature Genetics.

[8]  G. Casula,et al.  Outcomes for early rectal cancer managed with transanal endoscopic microsurgery , 2006, Surgical Endoscopy And Other Interventional Techniques.

[9]  R. Steele,et al.  Chromosomal changes in colorectal adenomas: Relationship to gene mutations and potential for clinical utility , 2006, Genes, chromosomes & cancer.

[10]  R. Lothe,et al.  The order of genetic events associated with colorectal cancer progression inferred from meta‐analysis of copy number changes , 2006, Genes, chromosomes & cancer.

[11]  G. Thomas,et al.  Retention of chromosome arm 5q in stage II colon cancers identifies 83% of liver metastasis occurrences , 2006, Genes, chromosomes & cancer.

[12]  Cisca Wijmenga,et al.  Reliable high-throughput genotyping and loss-of-heterozygosity detection in formalin-fixed, paraffin-embedded tumors using single nucleotide polymorphism arrays. , 2005, Cancer research.

[13]  Shigeru Chiba,et al.  A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. , 2005, Cancer research.

[14]  Lorena Losi,et al.  Evolution of intratumoral genetic heterogeneity during colorectal cancer progression. , 2005, Carcinogenesis.

[15]  N. Rao,et al.  Progress in concurrent analysis of loss of heterozygosity and comparative genomic hybridization utilizing high density single nucleotide polymorphism arrays. , 2005, Cancer genetics and cytogenetics.

[16]  I. Frayling,et al.  Systematic review of genetic influences on the prognosis of colorectal cancer , 2004, The British journal of surgery.

[17]  R. Goldbohm,et al.  APC mutations in sporadic colorectal carcinomas from The Netherlands Cohort Study. , 2004, Carcinogenesis.

[18]  B. Johansson,et al.  Tumor karyotype predicts clinical outcome in colorectal cancer patients. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  H. Meijers-Heijboer,et al.  Microsatellite Instability, Immunohistochemistry, and Additional PMS2 Staining in Suspected Hereditary Nonpolyposis Colorectal Cancer , 2004, Clinical Cancer Research.

[20]  Toshio Kuroki,et al.  Role of Smad4 (DPC4) inactivation in human cancer. , 2003, Biochemical and biophysical research communications.

[21]  Kazuyuki Suzuki,et al.  Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas , 2003, The Journal of pathology.

[22]  Mattias Höglund,et al.  Dissecting karyotypic patterns in colorectal tumors: two distinct but overlapping pathways in the adenoma-carcinoma transition. , 2002, Cancer research.

[23]  J. Arends,et al.  Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability. , 2002, Gastroenterology.

[24]  G. Noël,et al.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer , 2002 .

[25]  R. Fodde,et al.  The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade. , 2002, Human molecular genetics.

[26]  Rieken,et al.  [Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer]. , 2001, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[27]  이석호,et al.  Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study , 2001, British Journal of Cancer.

[28]  J. Tjandra,et al.  Local excision of rectal cancer , 2001, Diseases of the colon and rectum.

[29]  F T Bosman,et al.  Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma , 2001, International journal of cancer.

[30]  R. Houlston,et al.  What we could do now: molecular pathology of colorectal cancer , 2001, Molecular pathology : MP.

[31]  K. Kinzler,et al.  Mechanisms underlying losses of heterozygosity in human colorectal cancers , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J W Arends,et al.  Molecular interactions in the Vogelstein model of colorectal carcinoma , 2000, The Journal of pathology.

[33]  I. Schieren,et al.  Paradoxical increase in retinoblastoma protein in colorectal carcinomas may protect cells from apoptosis. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[34]  D. Bishop,et al.  K‐ras mutation and loss of heterozygosity of the adenomatous polyposis coli gene in patients with colorectal adenomas with in situ carcinoma , 1999, Cancer.

[35]  R. Orecchia,et al.  Intratumor heterogeneity of chromosome 1, 7, 17, and 18 aneusomies obtained by FISH and association with flow cytometric DNA index in human colorectal adenocarcinomas. , 1999, Cytometry.

[36]  J. Kononen,et al.  Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.

[37]  G. Fleuren,et al.  Evidence of clonal divergence in colorectal carcinoma , 1997, Cancer.

[38]  K Khosraviani,et al.  Colorectal adenoma-carcinoma sequence. , 1996, Gut.

[39]  Scott E. Kern,et al.  Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers , 1996, Nature Genetics.

[40]  E. Schröck,et al.  Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors , 1996, Genes, chromosomes & cancer.

[41]  D. Lane,et al.  p53, guardian of the genome , 1992, Nature.

[42]  R. Gope,et al.  Comparative study of the expression of Rb and p53 genes in human colorectal cancers, colon carcinoma cell lines and synchronized human fibroblasts , 1991, Molecular and Cellular Biochemistry.

[43]  T. Smyrk,et al.  Increased expression of the retinoblastoma gene in human colorectal carcinomas relative to normal colonic mucosa. , 1990, Journal of the National Cancer Institute.

[44]  Y. Sekido,et al.  Hepatocyte Growth Factor Reduces Susceptibility to an Irreversible Epidermal Growth Factor Receptor Inhibitor in EGFR-T790M Mutant Lung Cancer , 2010 .

[45]  Carsten Wiuf,et al.  Frequent occurrence of uniparental disomy in colorectal cancer. , 2007, Carcinogenesis.

[46]  D Bentley,et al.  Highly parallel SNP genotyping. , 2003, Cold Spring Harbor symposia on quantitative biology.

[47]  J. Hardcastle,et al.  Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.

[48]  G. Buess,et al.  Technique and results of transanal endoscopic microsurgery in early rectal cancer. , 1992, American journal of surgery.

[49]  D. Lane,et al.  Cancer. p53, guardian of the genome. , 1992, Nature.